Dear Editor,We report a rare case of bilateral central vision loss and color vision abnormalities after actinomycin D chemotherapy for a hydatidiform mole.Toxic optic neuropathy(TON)refers to a spectrum of disorders c...Dear Editor,We report a rare case of bilateral central vision loss and color vision abnormalities after actinomycin D chemotherapy for a hydatidiform mole.Toxic optic neuropathy(TON)refers to a spectrum of disorders characterized by bilateral visual loss,papillomacular bundle damage,central or cecocentral scotoma,and color vision abnormalities[1].展开更多
基金Supported by the Shanghai“Rising Stars of Medical Talents”Youth Development Program[No.SHWSRS(2023)_62]the Specialized Clinical Research Program of Shanghai Municipal Health Commission(No.20235Y0027)+1 种基金the Youth Project of the National Natural Science Fund(No.82000918)the Shanghai Sailing Program(No.20YF1404800).
文摘Dear Editor,We report a rare case of bilateral central vision loss and color vision abnormalities after actinomycin D chemotherapy for a hydatidiform mole.Toxic optic neuropathy(TON)refers to a spectrum of disorders characterized by bilateral visual loss,papillomacular bundle damage,central or cecocentral scotoma,and color vision abnormalities[1].
